Overall survival and updated progression-free survival outcomes in a randomized phase II study of combination cediranib and olaparib versus olaparib in relapsed platinum-sensitive... von Liu, J.F., Barry, W.T., Birrer, M., Lee, J.-M., Buckanovich, R.J., Fleming, G.F., Rimel, B.J., Buss, M.K., Nattam, S.R., Hurteau, J., Luo, W., Curtis, J., Whalen, C., Kohn, E.C., Ivy, S.P., Matulonis, U.A.

Volltext

A phase II study single agent of aflibercept (VEGF Trap) in patients with recurrent or metastatic gynecologic carcinosarcomas and uterine leiomyosarcoma. A trial of the Princess Ma... von Mackay, H.J, Buckanovich, R.J, Hirte, H, Correa, R, Hoskins, P, Biagi, J, Martin, L.P, Fleming, G.F, Morgan, R, Wang, L, Polintan, R, Oza, A.M

Volltext

Developing novel aldehyde dehydrogenase inhibitors to target ovarian cancer stem cells von Chefetz, I, Yang, K, Landen, C.N, Larsen, S.D, Buckanovich, R.J

Volltext

Cost-effectiveness analysis of tumor molecular classification in high-risk early-stage endometrial cancer von Orellana, T.J., Kim, H., Beriwal, S., Bhargava, R., Berger, J., Buckanovich, R.J., Coffman, L.G., Courtney-Brooks, M., Mahdi, H., Olawaiye, A.B., Sukumvanich, P., Taylor, S.E., Smith, K.J., Lesnock, J.L.

Volltext